| Literature DB >> 34390386 |
M F R Powell-Bowns1, E Oag2, D Martin2, N D Clement2, C E H Scott2,3.
Abstract
INTRODUCTION: The aim of this study was to identify factors associated with the level of periprosthetic fracture involving a cemented polished tapered stem: Vancouver B or Vancouver C.Entities:
Keywords: Osteoporosis; Periprosthetic femoral fracture; Total hip arthroplasty; Vancouver classification
Mesh:
Substances:
Year: 2021 PMID: 34390386 PMCID: PMC9522678 DOI: 10.1007/s00402-021-04113-6
Source DB: PubMed Journal: Arch Orthop Trauma Surg ISSN: 0936-8051 Impact factor: 2.928
Fig. 1Radiographic measurements of cortical thickness, femoral diameter and length of distal cement mantle
Fig. 2The different cement restrictors encountered in the study. From left to right: Hardinge, Exeter, Biostop. Yellow lines demonstrate how the distal cement mantle length was measured for the different cement restrictor types. For the Hardinge, the absolute distal cement mantle length was corrected to reflect folding up of the polyethylene device
Patient characteristics. Mean (SD) (range), number [%]
| Variable | |
|---|---|
| Male gender | 97 [54] |
| BMI | 27.1 (4.9) (17–39) |
| Age at primary (yrs) | 71.1 (10.8) (30–91) |
| Age at fracture (yrs) | 78.5 (11.5) (39–103) |
| Time to fracture (yrs) | 5.9 (5.4) (0.2–26.5) |
| Primary construct | |
| Bipolar hemiarthroplasty | 16 [9] |
| THA | 165 [91] |
| Cement restrictor | |
| Hardinge | 68 [38] |
| Biostop | 48 [27] |
| Exeter | 51 [28] |
| None | 14 [8] |
| Management | |
| ORIF | 152 [84] |
| Revision | 21 [12] |
| Non-operative | 8 [4] |
| Deceased | |
| 90-day mortality | 19 [10] |
| 1-year mortality | 37 [20] |
Fig. 3Periprosthetic fractures around the Exeter CPT stem according to the Vancouver classification and by location and pattern
Intraclass correlation of radiographic measurements
| Measure | Intraclass correlation | 95% CI | Cronbach’s alpha | |
|---|---|---|---|---|
| Distal cement mantle length | 0.786 | 0.71–0.84 | < 0.001 | 0.800 |
| Cortical thickness | 0.878 | 0.84–0.91 | < 0.001 | 0.878 |
| Femoral diameter | 0.956 | 0.94–0.97 | < 0.001 | 0.978 |
Patient characteristics by fracture level. Mean (SD), median (IQR), number [%]
| Variable | Vancouver B ( | Vancouver C ( | |
|---|---|---|---|
| Female gender | 65 [41] | 19 [90] | < 0.001^ |
| BMI | 27.0 (4.8) | 25.5 (4.0) | 0.289* |
| Age at primary implant | 70.6 (10.5) | 75.4 (11.8) | 0.064* |
| Age at fracture | 78.0 (11.2) | 77.4 (23.1) | 0.909* |
| Time from index surgery to fracture | 4.51 (1.3–9.3) | 3.88 (1.1–7.7) | 0.717** |
| SIMD | |||
| 1 | 23 [14] | 3 [17] | 0.534^ |
| 2 | 29 [18] | 1 [5] | |
| 3 | 22 [14] | 3 [17] | |
| 4 | 23 [14] | 5 [25] | |
| 5 | 46 [29] | 6 [33] | |
| Comorbidities and medications | |||
| Osteoporosis | 37 [23] | 8 [38] | 0.140^ |
| Steroids | 17 [11] | 1 [5] | 0.699^^ |
| NSAIDs | 22 [14] | 6 [29] | 0.080^ |
| Bisphosphonates | 24 [15] | 8 [38] | 0.010^ |
| Mortality | |||
| 90 day | 14 [9] | 5 [24] | 0.050^^ |
| 1 year | 29 [18] | 8 [38] | 0.033^ |
| Radiographic features | |||
| Bone–cement interface loosening | 22 | 2 | 0.745^^ |
| Femoral diameter (FD) (mm) | 29.9 (4.4) | 28.1 (5.0) | 0.123* |
| Cortical thickness (mm) | 6.98 (1.9) | 5.96 (1.3) | 0.017* |
| Cement restrictor | |||
| Hardinge | 61 | 7 | 0.234^ |
| Biostop | 43 | 5 | |
| Exeter | 46 | 5 | |
| None | 10 | 4 | |
| Dorr classification | |||
| A | 11 | 0 | 0.436^ |
| B | 10 | 1 | |
| C | 139 | 20 | |
| Distal cement mantle (DCM) (mm) | 18.4 (12.0) | 29.3 (19.1) | 0.001* |
| DCM/cortical thickness | 6.98 (1.9) | 5.96 (1.3) | 0.003* |
| DCM/FD ratio | 0.62 (0.43) | 0.94 (0.55) | 0.007* |
*Unpaired T test, **Mann–Whitney U test, ^Chi-squared, ^^Fisher’s exact